Metabolic Disorder Drugs Research Reports & Market Industry Analysis

Metabolic Disorder Drugs Research

3 comprehensive market analysis studies and industry reports on the Metabolic Disorder Drugs sector, offering an industry overview with historical data since 2019 and forecasts up to 2029. This includes a detailed market research of 25 research companies, enriched with industry statistics, industry insights, and a thorough industry analysis

3 Metabolic Disorder Drugs Reports

Hyperkalemia Treatments Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Sanofi S.A., Perrigo Company plc, CSL Limited (Vifor Pharma Management Ltd.), AstraZeneca, Ardelyx

Phenylketonuria Industry

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific

Major Players: BioMarin Pharmaceuticals, SOM Innovation Biotech SL , Homology Medicines Inc. , Censa Pharmaceuticals (PTC Therapeutics), Codexis Inc.

Lysosomal Storage Disease Treatment Market

Study Period: 2021 - 2029

Regions Covered: North America, Europe, Asia Pacific

Major Players: Pfizer Inc, Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi (Genzyme Corporation), BioMarin, Johnson & Johnson (Actelion Pharmaceuticals Ltd)

Metabolic Disorder Drugs Research

Categories

Related Metabolic Disorder Drugs Reports